维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="Romond EH"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2006	N Engl J Med2006，353，16：	1
2	Trastuzumab plus adju- vant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
3	Advances in adjuvant therapy for breast cancer显示文摘	Slamon DJ Romond EH Perez EA	2006	Clin Adv Hematol Oncol2006，4，37：	1
4	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
5	Four-year follow-up of trastu- zumab plus adjuvant chemotherapy for operable human epidermalgrowth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31 显示文摘	Perez EA Romond EH Suman VJ	2011	J Clin Oncol2011，29，25：	1
6	Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable hu- man epidermal growth factor receptor 2-positive breast cancer:joint analysis of data from NCCTG N9831 and NSABP B-31 显示文摘	Perez EA Romond EH Suman VJ	2011	J Clin Oneol2011，29，25：	1
7	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
8	Trastuzumab plus adjuvant chemotherapy for operable HER2 - positive breast cancer 显示文摘	Romond EH Perez EA Bryant J	2005	NEng!JMed2005，353，16：	1
9	Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast canc:joint analysis of data from NCCTG N9831 and NSABP B-31 显示文摘	Perez EA Romond EH Suman VJ	2011	J Clin Oncol2011，29，25：	1
10	Trastuzumab plus adjuvant chemotherapy for operable HER-2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
11	Allogeneicbone rnarrow transplantation with T cell -depleted partially matched related donors for davanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study显示文摘	Fleming DR Henslee- Downey PJ Romond EH	1996	Bone Marrow Transplant1996，17，5：	1
12	Trastuzumab plus adjuvant chemotherapy for operable HER - 2 - positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Eng J Med2005，353，16：	1
13	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	New Eugl J Meal2005，353，：	1
14	Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epider- mal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31 显示文摘	Perez EA Romond EH Suman VJ	2011	J Clin Oncol2011，29，25：	1
15	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer 显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
16	Trastuzumab plus adjuvant chemotherapy in HER-2-positive breast cancer 显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J IVied2005，353，16：	1
17	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
18	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1
19	Doxombicin and cyclophosphamide followed by paclitaxel with or without trastuzumab as adjuvant therapy for patients with HER-2 positive operable breast cancer 显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，555，16：	1
20	Trastuzumab plus adju- vant chemotherapy for operable Her2-positive breast cancer 显示文摘	Romond EH Perez EA Bryant J	2005	N Engl J Med2005，353，16：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示